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D 1 Definition and Nomenclature for Chronic Critical Limb Ischemia
D 1.1 Nomenclature
Clinicians generally agree on the type of patient described as having chronic critical limb
ischemia (chronic CLI), but attempts at a precise definition have been problematic. The clinical
concept is of patients with typical chronic ischemic rest pain or patients with ischemic skin
lesions, either ulcers or gangrene. This clinical description easily distinguishes patients with
chronic CLI from those with intermittent claudication alone, however severe the claudication
may be (see also B 1.1.1, Patient Characteristics in Intermittent Claudication, p S54), or
patients with a sudden onset of ischemia (see C 1.1, Definition of Acute Limb Ischemia,
pSI35). The term CLlshould only be used in relation to patients with chronic ischemic disease.
D 1.1.1 Historical Background
In 1954, Fontaine et all proposed a simple clinical classification of patients with ischemic rest
pain but no skin lesions as belonging to stage III PAD and patients who had skin lesions as
stage IV PAD. Chronic critical limb ischemia (CLI) can be used simply as a collective term for
these patients. CLI is also equivalent to the clinical description of grades II and III, which
includes categories 4, 5, and 6 of the North American recommendations for reporting stan-
dards .s The clinical distinction from claudicants has a pathological parallel; in claudicants, the
tissue ischemia is in the muscle and is intermittent. Patients with intermittent claudication have
no circulatory deficit or symptoms except when they exercise. By contrast, patients with ulcers
or gangrene have an impaired circulation to the skin most of the time . Patients without ulcers or
gangrene may only experience rest pain when their leg is horizontal and the perfusion pressure is
decreased . The problem with this simple classification is that the term chronic CLI (or Fontaine
III and IV) includes a whole spectrum of patients, from those with mild, easily controlled rest
pain to patients with extensive gangrene of the foot, in whom there is no alternative to an early
major amputation . However, intermittent claudication also encompasses a wide spectrum of dis-
ability.
Attempts have been made to subdivide the broad category of chronic CLI. In 1981, an ad hoc
working party met and published a definition of "Critical Ischaemia" in the British Journal of
Surgery.3 The definition is based on the concept of "limb-threatening ischemia," a term used to
describe ischemia of such severity that in the absence of a successful revascularisation the leg will
require a major amputation. The term limb salvage was added to describe this indication for
surgery, and the definition of critical limb ischemia then aims at defining this indication for limb
salvage surgery. The 1981 definition included an absolute ankle systolic Doppler pressure of less
than 40 mm Hg in patients with chronic ischemic rest pain and an ankle systolic pressure less
than 60 mm Hg in patients with ulcers or gangrene. The authors excluded patients with dia-
betes from the definition and did not offer any alternative definition to be applied to such
patients. On the basis of a Lyear follow-up of such patients, one of the authors of the original
recommendation suggested omitting any pressure limit for patients with ulcers or gangrene, but
retained the 40 -mm Hg pressure limits for patients with rest pain.t
Meanwhile, in 1986, a committee on reporting standards of the Society for Vascular Surgery
(SVS) and the North American Chapter of the International Society of Cardiovascular Surgery
(ISCVS) made a recommendation for clinical categories of chronic limb ischemia. This had the
same resting ankle pressure limit (40 mm Hg for rest pain, 60 mm Hg for nonhealing ulcers)
but added the possibility of measuring the toe pressure, which had to be below 30 mm Hg or
"a barely pulsatile ankle or metatarsal plethysmographic tracing." For patients with ulcers or
gangrene, the alternative of a toe pressure below 40 mm Hg was included in the definition.f
Next, a European Consensus Document on Chronic Critical Leg Ischaemia continued the same
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trend, that is, trying to define a group ofpatients who would inevitably require amputation in
the absence of successful revascularization. In that particular document, the same pressure limits
of 50 mm Hg at the ankle or 30 mm Hg at the toe were suggested for all patients with rest
pain, ulcers, or gangrene.s
More recently, Wolfe and Wyatt? analyzed the literature and suggested that a low-risk and a
high-risk group should be identified within patients with severe leg ischemia. They attempted to
calculate the major amputation rate at 1 year of patients in these two groups treated conserva-
tively (nonsurgically). The low-risk group contained only patients with rest pain alone and an
ankle pressure above 40 mm Hg. At 1 year, 73% of patients in this group lost their leg or died if
treated conservatively. The high-risk group contained patients with rest pain and an ankle pres-
sure less than 40 mm Hg and all patients who had ulcers or gangrene. Ninety-five percent of
these patients treated conservatively required an amputation or died within 1 year. They con-
cluded that "Reconstructive surgery should be viewed from the following, more realistic, per-
spective. For patients with rest pain (and/or ankle pressure over 40 mm Hg), 100%cumulative
patency is equivalent to 64% resolution of symptoms at one year as the rest pain in some (9%)
may have improved without treatment. For higher risk patients (tissue loss and/or ankle pres-
sure less than 40 mm Hg) 100% cumulative patency is equivalent to 93% limb salvageat one
year." Wolfe and Wyatt then went on to recommend that future reports should identify these
two groups separately? Their analysis may be unreliable, because most of the literature on which
the conclusions were based do not quote Doppler pressure, many include patients with intermit-
tent claudication, and many are postoperative series.
D 1.1.2 Problems With Recent Deftnitions of Chronic Critical Limb Ischemia
At least four problems arise with all of these post-Fontaine definitions if they are applied to the
clinical management of individual patients. The first is the impossibilityof defining prospectively
a group of patients who will inevitably require a major amputation in the absence of successful
revascularization unless the criteria are so severe that extremely few patients would qualify.
Severe, exclusive criteria may be justified in reporting practices or trial protocols for the purpose
of assuring that all limbs are truly at risk, bur these criteria are of limited use for clinical manage-
ment. As pointed out in the most recent "Recommended Standards for Reports Dealing With
Lower Extremity Ischemia" from the SVS and ISCVS, the term limbsalvage is a misnomer and
probably is best abandoned.I
The second problem with previous definitions attempting to identify a specific subgroup of
patients within the CLI group is that the division between subgroups is arbitrary and therefore
of little utility in lie management of individual patients. Indeed, the stimulus for all of these
more recent definitions has been the issue of reporting large series of patients with rest pain or
nonhealing ulcers treated in trials of a particular form of surgery or pharmacotherapy. A more or
less arbitrary division does not matter in that context. Third, ail post-Fontaine definitions of CLI
using arbitrary pressure limits exclude some patients with rest pain or possiblyeven ulcers, leav-
ing them in limbo; they are dearly not patients with intermittent claudication, but nor are they
patients with CLI by these definitions. Fourth, it is simply not known what would happen to a
patient with severe leg ischemia in the absence of treatment. Most information looks at patients
treated "conservatively," but they are clearly a selected subgroup in no way representative of all
patients with rest pain, ulcers, or gangrene. They are usuallypatients in whom a revasculariza-
tion procedure is not possible or has failed already.
D 1.1.3 Suggested Approach to Resolving the Problem
The current confusion may be partly clarified by clearly distinguishing between terms
used to describe individual patients and their clinical management from much more pre-
cise definitions used to describe a circumscribed group of patients in a clinical trial. The
former needs to be inclusive, and the latter can be exclusive. A clinical definition must
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include all individual patients who may present to a clinician, but a definition of a partic-
ular group of patients for trial protocol purposes can afford to exclude some patients.
Therefore, for everyday clinical practice, it is not helpful to refine the original Fontaine
classification.
The general inclusive term chronic critical limb ischemia (CLI) is proposed to include
patients with ischemic rest pain (Fontaine stage III) and patients with ischemic ulcers or
gangrene (Fontaine stage IV). PAD has to be proven objectively, normally by ABPI or toe
Doppler pressures. This term inevitably includes patients at very different levels of risk to
their leg, just as the term intermittent claudicant. includes patients with very different
claudication distances. It is proposed that the term CLI should be based solely on clinical
presentation of the patient and evidence that the rest pain, ulcers, or gangrene are pre-
dominandy caused by PAD. The evidence for PAD could equally well come from plethys-
mography, transcutaneous partial pressure of oxygen (TCPOz) measurement, duplex, or
angiography, and these are discussed in more detail in Investigations (see D 2.2, P 8178).
The term CLI is used in this clinical sense in this TASC document. The issue of defining a
circumscribed/homogenous group of patients, with an overall predictable outcome, for
clinical trial purposes, is discussed in Clinical Trial Issues in Critical Limb Ischemia, D6, p
8281 (see Recommendation 74).
Recommendation 73: Clinical definition of critical limb ischemia
The term critical limb ischemia should be used for all patients with chronic ischemic rest
pain, ulcers, or gangrene attributable to objectively proven arterial occlusive disease. The
term critical limb ischemia implies chronicity and is to be distinguished from acute limb
ischemia.
Recommendation 74: Trials and reporting standards definition of critical limb ischemia
A relatively inclusive entry criterion is favored, the aim being to ensure that the ulcera-
tion, gangrene, or rest pain is indeed caused by peripheral arterial disease and that most
would be expected to require a major amputation within the next 6 months to a year in
the absence of a significant hemodynamic improvement. To achieve this, it is suggested
to use absolute pressures of either
ankle pressure < 50-70 nun Hg or
reduced toe pressure «30-50 mm Hg) or
reduced TCPOz «30-50 mm Hg)
The features that make a particular patient with CLI more or less at risk are clearly described in
the epidemiological section (see A 2.7, Fate of Patients With Critical Limb Ischemia, p 523 ). For
instance, legs with rest pain are in general at less risk than legs with ulcers or gangrene; legs with
a low ankle systolicpressure are at greater risk than legs with a higher ankle systolic pressure.
The latest recommended set of standards for reports dealing with low-extremity ischemia from
the SVS and the ISCVS also raises a completely new issue. It identifies a particular subgroup of
patients with PAD who do not fall within the definitions of either claudication or chronic CLI.
These patients have severe PAD with low perfusion pressures and low ankle systolic pressures,
but are completely asymptomatic. They are sedentary and therefore do not claudicate, and if
they have managed to avoid trauma, they may not have ulcers or gangrene. In this asympto-
matic no-rnari 's-land, they are nevertheless very vulnerable, a small knock away from CLI. The
term chronicsubcriticai ischemia is suggested for these patients by the SVS/ISCVS document. 2
Confusion may arise because of an alternative use of the term subcritical ischemia by some
European authors to describe patients with ischemic rest pain but a comparatively high ankle
pressure ) say above 40 to 60 mm Hg. These patients are probably at a much lesser risk of
requiring a major amputation in the absence of successful rcvascularization than patients with
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rest pain and lower pressures or patients with ischemic ulcers and gangrene. Recognition of this
distinction is particularly important in the clinical trial and reporting context.
Critical Issue 27: High-risk patients not covered by current criteria for critical limb
ischemia
Because such patients may benefit from preventive measures and need to be followed-up
closely at frequent intervals to detect and deal with the development of manifestations
of critical limb ischemia, there is a need to identify and characterize a group of patients
with very low perfusion pressures and therefore high risk, but who may be asympto-
matic and not have claudication because of restricted activity, nor do they have critical
limb ischemia as defined in Recommendation 73.
Prognosis
The section on Epidemiology (A 2.7, p 523) details the various prognostic indicators for loss of
limb or death in patients with CLI. In general, the prognosis is dire and very much worse than
that of patients with intermittent claudication. It is impossible to describe the natural history of
these patients, because almost all patients diagnosed with CLI will, quite appropriately, be con-
sidered for active treatment, usually some form of revascularization. The minority of CLI
patients treated conservatively are in no way representative of the whole group. They will tend
to represent either the worst end of the spectrum, where no form of revascularization is techni-
cally possible, or revascularization has been tried and failed, or the best end of the CLI spec-
trum, with mild rest pain or ulcers without severe persistent rest pain.
There is, however, information on what happens to an unselected group of patients newly diag-
nosed with CLI and receiving the currently available standard therapy, In general, such informa-
tion suggests that a year after the onset of CLI, only about half the patients will be alive without
a major amputation, although some of these may still have rest pain, gangrene, or ulcers (see A
2.7, Epidemiology, p 523; A 2.8, P 523). Approximately 25%will have died, and 25% will have
required a major amputation. Again, in contrast to patients with intermittent claudication,
patients with CLI are on a rapidly downward course in terms of both life and limb, and current
noninterventional treatment or pharmacotherapy can help only a minority. Hence the increased
focus on developing new surgical, endovascular, and pharmacological approaches to the man-
agement of this small, but very seriously ill, group of patients. Their prognosis is in many ways
similar to that of some malignant forms of cancer.
Microcirculatory Pathophysiology in eLI
Although pathophysiology is not a primary topic in this Consensus document, understanding of
the general pathophysiologic changes in CLI is essential to optimal management of these patients.
Unfortunately, the precise pathophysiology of CLI in humans remains to be established. Current
knowledge is based largely on epidemiology in relation to risk factors, direct measurements in
patients, and extrapolation of results from animal and in vitro studiesf The macrocirculatory
defect is atherosclerosis. Deterioration in the macrocirculation and the perfusion pressure to the
limb results from gradual increase in the atherosclerosis, with more sudden episodes of deteriora-
tion caused by superimposed thrombosis. Local thrombosis may be lie result of the activation of
platelets and leukocytes as they come into contact with ulcerated or ruptured atherosclerotic
plaques, possibly accompanied by downregulations in local anti-thrombotic defense mechanisms.
The special case of patients with diabetes is discussed in The Diabetic Foot (Dl. 4, P SI73).
eLI occurs when arterial stenoses or occlusions impair blood flow to such an extent that despite
compensatory mechanisms such as collateral formation, the nutritive requirements of lie periph-
eral microcirculation cannot be met. This is usually caused by multilevel disease.? In some cases;
the hemodynamic consequences of arterial lesions may be compounded by chronic venous
insufficiency or decreased cardiac output.
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A number of newer techniques have improved the understanding of the skin microcirculation,
which is the pathological target tissue in most CLI patients. These include capillaroscopy.U' flu-
orescence videomicroscopy, 10,11 laser Doppler fluxmetry--' and TCP02 measurements.lf In
contrast to the early stages of PAD, in which compromised skeletal muscle blood flow causes
intermittent claudication, rest pain and trophic changes associated with CLI are predominantly
attributable to a critical reduction in skin microcirculation. The skin microcirculation is unusual
in many ways, most notably that nutritional capillary blood flow only represents approximately
15% of the normal total blood flow in the foot, the remainder having a thermoregulatory func-
tion only. 10
The normal function of the skin microcirculation can be considered under two headings: a com-
plex microvascular flow regulatory system and a series of defense mechanisms. The microvascu-
lar flow-regulating system includes extrinsic neurogenic mechanisms, intrinsic local mediators,
and modulation by circulating humoral and blood-borne factors. The endothelium also partici-
pates in the regulation of flow by the release of vasodilatory mediators such as prostacyclin and
endothelium-derived relaxing factor nitric oxide and several endothelium-derived contractile fac-
tors (eg, endothelin). In addition to the microvascular flow-regulating system, there are several
microvascular defense mechanisms. The inappropriate activation of hemostasis and inflammation
also playa central role in the pathophysiology of CLI. In CLI, there is a maldistribution of the
skin microcirculation in addition to a reduction in total blood flow. The importance of the local
microcirculatory response in individual patients with CLI is suggested by the wide overlap in
ankle or toe blood pressure, which assess the macrocirculation, in patients with and without
CLI.
Capillary microscopy studies have confirmed an inhomogeneous distribution of skin microcircu-
latory flow. This is accompanied by a reduction in TCP02 .13 The final sequence of events lead-
ing to decreased capillary perfusion in CLI is not established. Possible contributory causes are
collapse of precapillary arterioles caused by low transmural pressure, arteriolar vasospasm, abnor-
mal vasomotion, microthromboses, collapse of capillaries caused by interstitial edema, capillary
occlusion from endothelial cell swelling, platelet aggregates, rigid adhesive leukocytes, or blood
cells/platelet aggrcgares.H Activation of platelets and leukocytes and damage ofvascular
endothelium may result in vicious cycles between these inappropriately activated cells through a
number of mediators.
A variety of markers of blood coagulation have been detected in conjunction with PAD. These
may favor fibrin formation as well as alterations in blood fibrinolytic potential, which may inhib-
it fibrin dissolution, for example, high levels of plasminogen activator inhibitor. There is also
increasing evidence that leukocytes play an important role in ischemic disease.If Activated leuko-
cytes are abnormally rigid and therefore candidates for microvascular occlusion. Finally, in the
presence oflocal infections, it is probable that the above mechanisms are amplified and com-
pounded by the release of bacteria-derived toxins from the cellular and immunological
rcsponse.Js Although hypothetical because they are mainly extrapolated from animal and in
vitro studies, two mediators, namely EDRF (nitric oxide) and prostacyclin, may be particularly
important in deactivating the inappropriately activated cells and reestablishing flow. Besides its
vasodilatory properties, EDRF inhibits platelet activation synergistically with prostacyclin.l?
In summary, although PAD is the underlying and principal defect in patients with CLI, the low
tissue perfusion pressure sets up a number of complex local microcirculatory responses, which
are the ultimate cause of the rest pain and trophic changes. Many of these processes can be
viewed as an inappropriate response of the microcirculatory flow regulatory mechanism and its
normal defense mechanisms. The result is a series of auto-multiplying vicious cycles. Therefore,
although the primary aim of treatment must be the correction of the PAD, attempts to manipu-
late and normalize the microcirculatory changes pharmacologically may enhance the results of
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revascularization and may be the best option in patients in whom revascularization is impossible
or has failed.
The Diabetic Foot
The management of gangrene or ulcers in diabetic patients is more difficult than in nondiabetic
patients, as evidenced by the many times greater need for major amputation for predominant
ischemic disease in the former compared with the latter (see A 2.9, Major Amputation, p 824).
Eighty-five percent of diabetes related lower-extremity amputations are preceded by a foot ulcer.
The management of the diabetic with CLI also illustrates particularly well the need for a multi-
disciplinary approach to the treatment of CLI patients in general. There are reports claiming
that a multidisciplinary approach, including prevention, patient education, and multifactorial
treatment of foot ulcers reduces amputation rate by 43% to 85%.18
Diabetes is an important risk factor for the development of atherosclerosis, which becomes clini-
cally manifest 5 to 10 times more commonly in diabetic patients than in nondiabetic patients.J?
There is general agreement that diabetic atherosclerosis is more diffuse, more severe, and mani-
fests itself at an earlier age than atherosclerosis in nondiabetic patients.20,21 The significance of
diabetic microangiopathy, that is, additional arteriolar and capillary disease, is more controver-
sial. The problem of the diabetic foot is complicated by the frequent coexistence of diabetic
neuropathy, which can involve sensory, motor, and autonomic nerve fibers. As a consequence of
reduced sensation of pain and temperature, diabetic patients with sensory neuropathy may not
be able to notice environmental thermal changes, pressure from poorly fitting shoes, and other
trauma.P This will predispose to ulceration, gangrene, and infection (see also D 4.2.2, Foot
Care in Patients With Critical Limb Ischemia, p 8194).
Motor nerve defects and limited joint mobility may cause foot deformities, pressure points fur-
ther predisposing to foot lesions. Local consequences of autonomic abnormalities include loss of
sweating, dry fissured skin, and increased arteriovenous shunting. Poorly controlled diabetic
patients are more prone to infection than those who are well controlled. Bacterial growth is
reported to be inhibited by lactic acid, but in the presence ofdiabetic ketoacidosis, this inhibi-
tion of bacterial growth is reduced. Finally, the immune system is also altered in diabetic
patients and antibody function may be modified as a result of glycosylation (see also
Recommendation 23).
Management Plan
Prompt and appropriate referral
All patients with ulcers, gangrene, or pain in the foot possibly attributable to PAD should be
considered an urgent case. The leisurely investigation of these patients in a nonspecialized pri-
mary care setting is quite inappropriate. They should be referred promptly to a vascular special-
ist center with expertise in treating patients with CLI. This should include availability of all the
specialist services that may be required for the complete characterization and subsequent treat-
ment of these difficult cases. Failure to do so promptly may increase tile patientis risk of losing a
leg. It is, however, an unfortunate fact that many patients with CLI are still investigated and
treated in nonspecialized centers.
Recommendation 75: Prompt referral of patients with critical limb ischemia
Prompt referral of patients with critical limb ischemia to a vascular specialist will
improve the chances of successful treatment.
Multidisciplinary team approach
Because patients with CLI are likely to have overt or subclinical multisystem disease, a multidis-
ciplinary team approach would seem sensible for the diagnosis, assessment, and treatment of
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these patients, requiring the services of a wide variety of specialists. The conflicting interests of
different single specialties cannot be in the best interest of the patient. It is therefore one of the
purposes of this consensus document to obtain multidisciplinary agreement on broad aspects of
patient management.
Recommendation 76: Multidisciplinary approach in critical limb ischemia
Close cooperation between disciplines is particularly desirable for the timely diagnosis
and treatment of both diabetic and nondiabetic patients with critical limb ischemia.
Establishing the diagnosis
This is discussed in detail in Evaluation (D 2.2, P 5178). The first step is to establish whether
the patienns disease is predominantly caused by PAD and to what degree the presenting prob-
lem is compounded by other pathologies such as venous thrombosis, diabetic neuropathy, or
cardiac failure. Alternative causes of foot pain or ulcers should be excluded (see Differential
Diagnosis, D 2.3, P 5184). The urgency of the case should be individually assessed, because
this will have a bearing on more detailed investigations. In general, patients with rest pain alone
pose less of an urgent problem than patients with trophic changes. The principal cause for great
urgency is the coexistence of locally spreading or systemic infection and a possible recent throm-
botic role in the pathophysiology.
Detailed assessment
This is discussed in detail in Evaluation (D 2. 2, P 5178). The two principal aims of further
investigation of these patients is to delineate the precise anatomy of the arterial disease and the
detection and quantification of coexisting disease in other systems. Imaging of the full arterial
supply to the legs is crucial in virtually all cases of CLI.
Treatment plan
This is discussed in detail in Treatment (D 4, P 5192). The treatment plan for CLI, as well as
any coexisting disease, is best formulated by discussion between relevant specialists. This is
accepted as best practice in most specialized vascular centers dealing with CLI. The progress of
treatment should be regularly reviewed, again preferably by a multidisciplinary team.
Follow-up
Patients with CLI may be successfully treated in terms of resolution of the rest pain and healing
of trophic skin changes, but they are never completely or permanently cured. The underlying
PAD will continue to progress, even if its rate of progression may be slowed down. Recurrence
of CLI is common. All such patients should therefore be regularly followed-up, again preferably
in a specialized center. It is important to consider a surveillance program for patients who have
had revascularization procedures, because this undoubtedly improves secondary and assisted pri-
mary patency and limb survival (see D 4.14, Surveillance, p 5253).
Audit
Follow-up is also essential to obtain complete audit data. Treatment decisions must be based on
the results obtained in the center concerned. Too often in the past, decisions about the risks
and benefits of a particular treatment were based on published data, which is sometimes incom-
plete, sometimes based on a different patient population, and sometimes obtained by practition-
ers with a level of skill that cannot be reproduced in other centers. Alternatively, publications
may be based on outdated studies that do not reflect improvements in systemic and local care,
diagnostic refinements, and new drugs and interventional technology. It is therefore essential
that each specialized center should audit its own results, to set its standards, judge its level of
expertise, and influence ongoing decisions about patient management.
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Recommendation 77: Audit in critica1limb ischemia
It is recommended that all units dealing with critical limb ischemia should maintain
accurate, audited records for all patients treated and their progress. The minimum fol-
low-up analysis should be in terms of J-year re-interventions, re-admissions, amputa-
tion rates, mortality, and, ideally, other outcome measures.
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